Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity
Although treatment outcomes of glioblastoma, the most malignant central nervous system (CNS) tumor, has improved in the past decades, it is still incurable, and survival has only slightly improved. Advances in molecular biology and genetics have completely transformed our understanding of glioblasto...
Main Authors: | Gábor Hutóczki, József Virga, Zsuzsanna Birkó, Almos Klekner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/10005 |
Similar Items
-
Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
by: Zsuzsanna Birkó, et al.
Published: (2020-10-01) -
Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients
by: Dóra Géczi, et al.
Published: (2021-05-01) -
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
by: Stefano Guadagni, et al.
Published: (2020-03-01) -
The role of extracellular vesicles in the diagnosis of glioblastoma progression
by: A. I. Ryabova, et al.
Published: (2020-11-01) -
Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
by: Ander Saenz-Antoñanzas, et al.
Published: (2019-07-01)